Inventor · disambiguated record
Stuart H. Orkin
Also filed as: ORKIN STUART · ORKIN STUART H
14 granted patents·5 pending applications·97 citations·filing 1990–2023
92Inventor score
Files withCHILDRENS MEDICAL CT CORP8CHILDRENS MEDICAL CENTER5BROAD INST INC3CHILDREN'S MEDICAL CENTER CORP1DANA FARBER CANCER INST INC1
Top patents by PatentIndex Score
19 records- 0195US9885041B2Modulation of BCL11A for treatment of hemoglobinopathiesCHILDRENS MEDICAL CENTER·Filed 2016·Granted Feb 6, 2018·15 cites·14 claims
- 0294US8383604B2Modulation of BCL11A for treatment of hemoglobinopathiesCHILDRENS MEDICAL CENTER·Filed 2009·Granted Feb 26, 2013·25 cites·11 claims
- 0393US9228185B2Modulation of BCL11A for treatment of hemoglobinopathiesCHILDRENS MEDICAL CT CORP·Filed 2013·Granted Jan 5, 2016·13 cites·23 claims
- 0488US11572543B2Targeting BCL11A enhancer functional regions for fetal hemoglobin reinductionCHILDRENS MEDICAL CT CORP·Filed 2016·Granted Feb 7, 2023·4 cites·7 claims
- 0587US10266826B2Modulation of BCL11A for treatment of hemoglobinopathiesCHILDRENS MEDICAL CT CORP·Filed 2018·Granted Apr 23, 2019·4 cites·32 claims
- 0686US11021696B2Nuclease-mediated regulation of gene expressionCHILDRENS MEDICAL CENTER·Filed 2014·Granted Jun 1, 2021·4 cites·6 claims
- 0786US9822355B2Targeting BCL11A distal regulatory elements for fetal hemoglobin reinductionCHILDREN'S MEDICAL CENTER CORP·Filed 2013·Granted Nov 21, 2017·8 cites·14 claims
- 0884US11685917B2Functional genomics using CRISPR-Cas systems for saturating mutagenesis of non-coding elements, compositions, methods, libraries and applications thereofBROAD INST INC·Filed 2017·Granted Jun 27, 2023·2 cites·37 claims
- 0982US10308926B2Stablized EZH2 peptidesDANA FARBER CANCER INST INC·Filed 2014·Granted Jun 4, 2019·3 cites·43 claims
- 1081US12497610B2Functional genomics using CRISPR-CAS systems for saturating mutagenesis of non-coding elements, compositions, methods, libraries and applications thereofBROAD INST INC·Filed 2023·Granted Dec 16, 2025·0 cites·6 claims
- 1179US10570392B2Modulation of BCL11A for treatment of hemoglobinopathiesCHILDRENS MEDICAL CT CORP·Filed 2019·Granted Feb 25, 2020·1 cites·27 claims
- 1279US2023348887A1Targeting bcl11a distal regulatory elements for fetal hemoglobin reinductionCHILDRENS MEDICAL CT CORP·Filed 2022·Application pending·0 cites
- 1378US2024167018A1Functional genomics using crispr-cas systems for saturating mutagenesis of non-coding elements, compositions, methods, libraries and applications thereofBROAD INST INC·Filed 2023·Application pending·0 cites
- 1476US10472619B2Targeting BCL11A distal regulatory elements for fetal hemoglobin reinductionCHILDRENS MEDICAL CT CORP·Filed 2017·Granted Nov 12, 2019·1 cites·14 claims
- 1571US11542493B2Targeting BCL11A distal regulatory elements for fetal hemoglobin reinductionCHILDRENS MEDICAL CT CORP·Filed 2019·Granted Jan 3, 2023·0 cites·16 claims
- 1668US2025313649A1Compositions and methods for targeted protein degradationCHILDRENS MEDICAL CT CORP·Filed 2023·Application pending·0 cites
- 1766US2021348143A1Nuclease-mediated regulation of gene expressionCHILDRENS MEDICAL CENTER·Filed 2021·Application pending·0 cites
- 1858US8597910B1DNA encoding Von Willebrand Factor (VWF) and methods and cells for producing VFW, and VFW produced by the DNA, methods and cellsGINSBURG DAVID·Filed 1990·Granted Dec 3, 2013·17 cites·36 claims
- 1941US2014271657A1Combinatorial compositions and methods of treating hemoglobinopathiesCHILDRENS MEDICAL CENTER·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Stuart H. Orkin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →